Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-010389
Filing Date
2025-03-14
Accepted
2025-03-14 16:30:35
Documents
75
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2346279
2 ex3-9.htm EX-3.9 52561
3 ex10-25.htm EX-10.25 403385
4 ex10-26.htm EX-10.26 134239
5 ex10-27.htm EX-10.27 35848
6 ex10-28.htm EX-10.28 112842
7 ex23-1.htm EX-23.1 5474
8 ex31-1.htm EX-31.1 12071
9 ex31-2.htm EX-31.2 12458
10 ex32-1.htm EX-32.1 7734
11 ex32-2.htm EX-32.2 7796
12 form10-k_001.jpg GRAPHIC 12818
  Complete submission text file 0001493152-25-010389.txt   7602987

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE ogen-20241231.xsd EX-101.SCH 35453
14 XBRL CALCULATION FILE ogen-20241231_cal.xml EX-101.CAL 53025
15 XBRL DEFINITION FILE ogen-20241231_def.xml EX-101.DEF 127190
16 XBRL LABEL FILE ogen-20241231_lab.xml EX-101.LAB 378365
17 XBRL PRESENTATION FILE ogen-20241231_pre.xml EX-101.PRE 287048
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 677818
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32188 | Film No.: 25740488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)